Detection of phenolic glycolipid I of Mycobacterium leprae in sera from leprosy patients before and after start of multidrug therapy
about
Advances and hurdles on the way toward a leprosy vaccine.Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosyThe influence of innate and adaptative immune responses on the differential clinical outcomes of leprosy.High prevalence of vasomotor reflex impairment in newly diagnosed leprosy patients.Rational design and evaluation of a multiepitope chimeric fusion protein with the potential for leprosy diagnosisAnalysis of antibody and cytokine markers for leprosy nerve damage and reactions in the INFIR cohort in India.Infection during infancy and long incubation period of leprosy suggested in a case of a chimpanzee used for medical researchLeprosy and the human genomeInsight toward early diagnosis of leprosy through analysis of the developing antibody responses of Mycobacterium leprae-infected armadillos.Antigen-specific assessment of the immunological status of various groups in a leprosy endemic region.Limited susceptibility of cynomolgus monkeys (Macaca fascicularis) to leprosy after experimental administration of Mycobacterium lepraeUse of protein antigens for early serological diagnosis of leprosy.Multibacillary leprosy patients with high and persistent serum antibodies to leprosy IDRI diagnostic-1/LID-1: higher susceptibility to develop type 2 reactions.Selection of antigens and development of prototype tests for point-of-care leprosy diagnosis.Serological diagnosis of leprosy in patients in vietnam by enzyme-linked immunosorbent assay with Mycobacterium leprae-derived major membrane protein II.Divergence of macrophage phagocytic and antimicrobial programs in leprosyEvaluation and Monitoring of Mycobacterium leprae Transmission in Household Contacts of Patients with Hansen's Disease in Colombia.ML0405 and ML2331 are antigens of Mycobacterium leprae with potential for diagnosis of leprosy.Hansen's Neuritis Revisited - A Clinicopathological Study.Mycobacterium leprae-Specific Antibodies in Multibacillary Leprosy Patients Decrease During and After Treatment With Either the Regular 12 Doses Multidrug Therapy (MDT) or the Uniform 6 Doses MDT.IgM Anti PGL-1 Antibody Level in Patients with Leprosy: A Comparative Study between Ear Lobes Capillary and Median Cubital Vein Blood Samples
P2860
Q22305432-FA9ED2C3-2E94-47FA-A714-BEE3572DBC0FQ26749927-C600B5F5-B5CF-4E44-817D-6E057E725AD2Q30238551-E0C7B296-F47B-4DDC-8EE6-51E5E29357EFQ33223827-07CFD8F9-F0B1-4964-96D3-9B97B0E3438FQ33627089-56002D61-3EE9-4D86-B9C2-3CB2C0E56B7BQ33847430-F148611A-0412-4D63-B6B7-86FF82EB9CCAQ34120574-2AEA5A27-DD60-4207-9874-3C6A1F31B0A2Q34431856-9AFBD7C7-2375-4A7C-9B11-DDE46455C51DQ34738846-8B799DE5-8689-4ACA-8E97-FA639A1BC403Q35645291-1AC53675-8E7D-43E2-A2B4-9ED5F44D81E0Q36149666-3208F0AC-5F85-4A31-A079-E5715F61AAB2Q36313571-97E7A6AD-3277-439E-878C-4766AF236D83Q36321464-87DAF3A8-19AF-4D23-AB8D-664A948190D0Q36933064-E442E947-5727-4DEE-A6DB-4DF40785A937Q36994270-E01C50F4-55B5-4AFA-99A8-A90840016B87Q37393776-720B3570-3F5E-4A3B-A7E5-4DBBBE2DEAF6Q37621706-A170A8C2-E316-4ABD-A367-63957A351D3AQ42219730-233888FD-3E15-4152-8FE0-18BD6045F2DAQ49885754-C2CF4A63-569A-4883-8014-054C8F8B1559Q55287217-BDB9DD0A-4A48-432F-8372-BBE12D8B43E6Q58773473-EDED2A64-0F1B-4052-842D-2449AEC905E3
P2860
Detection of phenolic glycolipid I of Mycobacterium leprae in sera from leprosy patients before and after start of multidrug therapy
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Detection of phenolic glycolip ...... ter start of multidrug therapy
@ast
Detection of phenolic glycolip ...... ter start of multidrug therapy
@en
type
label
Detection of phenolic glycolip ...... ter start of multidrug therapy
@ast
Detection of phenolic glycolip ...... ter start of multidrug therapy
@en
prefLabel
Detection of phenolic glycolip ...... ter start of multidrug therapy
@ast
Detection of phenolic glycolip ...... ter start of multidrug therapy
@en
P2093
P2860
P1476
Detection of phenolic glycolip ...... ter start of multidrug therapy
@en
P2093
L G Villahermosa
M V Balagon
P J Brennan
R M Abalos
R V Cellona
T T Fajardo
P2860
P304
P356
10.1128/CDLI.8.1.138-142.2001
P577
2001-01-01T00:00:00Z